Find Academic Supervisors

• Bioactive (chromo)peptides from algae
• Protein-ligand interactions relevant for food systems
• Protein stability at high pressures
• +1 more

Simeon L. Minic serves as an Assistant Professor in the Department of Biochemistry at the Faculty of Chemistry, University of Belgrade, having progressed through academic ranks from Researcher-intern (2017) to his current position since 2023. His career trajectory reflects dedicated service within the same institution, including roles as Research Associate (2018-2021) and Senior Research Associate (2022). Dr. Minic completed all academic training at the University of Belgrade - Faculty of Chemistry: Basic Academic Studies in Chemical Sciences (2008-2012), Master of Academic Studies (2012-2013), and Doctorate in Chemical Sciences (2013-2017). His educational foundation underpins his specialized research in bioactive compounds from algae and protein interactions. His research program centers on bioactive chromopeptides from algae , protein-ligand interactions in food systems , protein stability under high pressure , and development of cell culture media . These interconnected themes drive innovation in sustainable food technologies, particularly for algae-based colorants, nutraceuticals, and cultured meat applications. His work bridges fundamental biochemistry with practical food science challenges. Analysis of his 15 most recent publications (2015-2022) reveals consistent focus on phycobiliproteins from algae (particularly phycocyanobilin) and their interactions with dairy proteins (β-lactoglobulin, serum albumin, α-lactalbumin). The research combines multi-spectroscopic techniques , molecular dynamics simulations , and functional property assessment to address stability, binding mechanisms, and applications in food coloring, fortification, and health. Emerging trends show increasing emphasis on sustainable food systems, including microplastic toxicity and cultured meat media development. Dr. Minic's scientific recognition includes: First place in Montenegro's republican chemistry competition (2008) Đorđe Stefanović Diploma as top biochemistry student (2013) University of Belgrade Student Award (2013) Serbian Chemical Society Annual Award (2013) FEBS scholarships for international research (2015, 2022) He teaches core biochemistry courses including Regulation of Biochemical Processes, Enzymology, and Biochemistry of Food and Nutrition. As principal investigator, he leads four major international projects: IMPTOX (Horizon 2020 microplastics study), PRESSION (algae protein fortification using high pressure), ALG2MEAT (algae extracts for cultured meat), and Pep4Meat (algae chromopeptides as serum replacement). These projects, funded by the European Commission, ANSO, Good Food Institute, and Serbian Science Fund, demonstrate significant research leadership. His laboratory work operates within the Department of Biochemistry at Belgrade's Faculty of Chemistry, collaborating with international consortia. Dr. Minic actively contributes to the Serbian Chemical Society, Biochemical Society of Serbia, and Serbian Proteomics Association, maintaining strong professional networks in food biochemistry and protein science.

Murali VijayanView profile

Academic

• Alzheimer's Disease
• Mitochondrial Biology
• MicroRNA Biology
• +3 more

Murali Vijayan, Ph.D., is a Research Assistant Professor at the Texas Tech University Health Sciences Center within the Department of Internal Medicine . With expertise in mitochondrial biology , microRNA research , and genetics , his work focuses on Alzheimer's disease and other neurodegenerative conditions. He works under Dr. P. Hemachandra Reddy's mentorship and is affiliated with the Institute for One Health Innovation . Research Interests: Vijayan's research bridges molecular mechanisms with clinical applications, targeting: MicroRNA regulation in ischemic stroke and dementia Mitochondrial dysfunction in neurodegeneration Small molecule interventions for Alzheimer's disease Genetic risk factors for stroke and diabetes Mitophagy and synaptic protection Multi-omics approaches to neurological disorders Publication Trends: His 15 most recent articles (2014-2025) demonstrate consistent focus on Alzheimer's disease (8 papers), mitochondrial biology (11 papers), and microRNA regulation (7 papers). Key subfields include neurogenetics , transgenic disease models , and oxidative stress pathways . Scientific Recognition: Vijayan has received: 2024: Texas Alzheimer's Research and Care Consortium Junior Investigator Grant 2024: American Heart Association Career Development Award 2019: Employee of the Year for Research 2017: Best Oral Presentation Award for Stroke Biomarkers 2016: Newton International Fellowship 2012: FIMSA/IIS Travel Bursary 2010: Junior Research Fellowship Grants & Collaborations: His research has been supported by multiple grants, particularly focusing on Alzheimer's disease and mitochondrial dysfunction . He collaborates with institutions across Texas Tech University's health sciences network and works with interdisciplinary teams studying the intersection of metabolic disorders and neurological conditions.

Aditi BanerjeeView profile

Associate Professor

• Cancer Biology
• Endoplasmic Reticulum Stress
• Signal Transduction
• +5 more

Dr. Aditi Banerjee is an Associate Professor in the Department of Pediatrics at the University of Maryland School of Medicine. Her research focuses on cancer biology, specifically targeting endoplasmic reticulum (ER) stress pathways and hypoxia-induced ischemia neuroprotection. She has developed innovative models using colon cancer spheroids and patient-derived organoids to study chemotherapeutic efficacy. Research Keywords: Unfolded Protein Response, Endoplasmic Reticulum Stress, Oncogene-Tumor Suppressor Signaling, and Molecular Mechanisms of Hypothermia. Scientific Contributions : First to identify FoxM1-RASSF1A signaling crosstalk in metastatic colon cancer Developed combinatorial therapies targeting ER stress pathways Collaborated with Dr. Jaylyn Waddell to study neonatal brain pathology Selected Awards : Travel Awards from ASBMB (2008, 2010) Best Poster Award, Pediatrics Research Day (2022) Advisory Board Member, Cellular and Molecular Life Sciences (2021)

• Transplantation
• Organ Preservation
• Biopreservation
• +5 more

Timothy Pruett, MD is a Professor of Surgery and Internal Medicine at the University of Minnesota, specializing in the Division of Transplantation. His clinical and research work spans liver, kidney, and islet transplantation with expertise in organ preservation, biopreservation, and machine learning applications for improving transplant outcomes and allocation systems. His research addresses frailty assessment in transplant candidates using CT-derived body composition metrics, predictive modeling for liver disease progression (including the 'MELDPredict' tool), and ethical governance frameworks for emerging biopreservation technologies. He investigates immunosuppression minimization strategies, donor data analysis through AI, and the impact of sarcopenia on post-transplant recovery. Recent 2025 publications demonstrate heavy integration of artificial intelligence in transplantation medicine, featuring tools for donor allocation, biopreservation advancements, and policy analysis. Key themes include deep learning for sarcopenia assessment, ethical considerations in organ allocation, and HIV-related transplantation challenges, reflecting his dual focus on technological innovation and systemic policy reform. Dr. Pruett leads the multicenter Prospective Observational Study of TPIAT (POST) consortium and collaborates with interdisciplinary teams across surgery, internal medicine, and data science to enhance transplantation practices and patient quality of life.

Sung Mun LeeView profile

Associate Professor

• Biomedical Engineering
• Drug Delivery Systems
• Nanomedicine
• +3 more

Dr. Sung Mun Lee is an Associate Professor at Khalifa University's Department of Biomedical Engineering. His work focuses on strategic design of drug delivery systems, development of novel biomaterials for nanomedicine, and targeting reactive oxygen species (ROS) in inflammatory diseases. Education: Ph.D. from Texas A&M University M.Sc. from Seoul National University B.S. from Korea University Research interests span ROS scavenging for diabetes and atherosclerosis, siRNA delivery to Kupffer cells in acute liver failure, nanoparticle engineering for protein protection, and targeted therapies for macrophages. His recent publications highlight interdisciplinary work in cancer therapy, oxidative stress diagnostics, organ-on-a-chip modeling, and bioprinting of functional tissues. Current projects include: Zein nanoparticles for oral therapeutic protein delivery Monocyte-based ROS scavenging systems for atherosclerosis Polyketal microparticles for siRNA delivery in acute liver failure Conductive MXene-gold bioinks for skeletal muscle engineering Dr. Lee teaches Biomedical Engineering Fundamentals (BMED351) and Biotransport Phenomena (BMED331) , and leads research groups at the Healthcare Engineering Innovation Group and Center for Biotechnology Research.

Ketema PaulView profile

Professor

• Sleep Regulation
• Circadian Biology
• Neurobiology
• +3 more

Ketema Paul is a Professor in the Department of Integrative Biology and Physiology at the University of California, Los Angeles (UCLA). After completing his Ph.D. in Biology at Georgia State University, he conducted postdoctoral research at Northwestern University's Center for Sleep and Circadian Biology and held a faculty position at Morehouse School of Medicine before joining UCLA in 2016. Education: B.S. in Biology from Howard University (1994), Ph.D. in Biology from Georgia State University (2003) His research focuses on the neural, genetic, and hormonal regulation of sleep, with three primary areas: sex differences in sleep mechanisms, circadian molecules' role in recovery from sleep loss, and genetic heterogeneity in resilience to sleep deprivation. His lab uses forward genetics in mice and examines circadian gene expression in Alzheimer’s Disease patients' blood cells. Recent publications highlight his interest in sleep's interaction with stress resilience, neurodegenerative diseases (e.g., Alzheimer’s), muscle physiology, and genetic models of Huntington’s Disease and Dup15q syndrome. Collaborations span neuroscience, nutrition, and chronobiology fields. He maintains an active research program at the UCLA Paul Lab , with a focus on identifying novel sleep-regulatory genes and therapeutic targets for sleep disorders.

Verónica Contreras-ShannonView profile

Professor

• Biomedical Research
• Metabolic Disorders
• Neuroimmunology
• +4 more

Verónica Contreras-Shannon, Ph.D., is a Professor of Biological Sciences at St. Mary’s University in San Antonio, Texas. She specializes in biomedical research focusing on metabolic side effects of atypical antipsychotics and cytoskeletal dynamics in disease states, particularly atherosclerosis and muscle regeneration. Her teaching portfolio includes General Biology for Majors, Toxicology, and Cell and Molecular Methods Lab, where she employs evidence-based practices like course-based research experiences to enhance student engagement. Education: Ph.D. in Biochemistry from UTHSCA (2003), B.A. in Biology from UC Santa Cruz (1995) Research Programs: Director of NIH-funded U-RISE and MARC programs for undergraduate research training Awards: Distinguished Faculty Award (2019), NIH SCORE Pilot Project Award (2018), Undergraduate Research Mentor Award (2012), Senior Faculty Research Mentoring Award (2023) Her research involves undergraduate students in studying: Mechanisms of metabolic side effects from antipsychotics Cytoskeletal roles in disease phenomena Beta-tubulin isotype involvement in foam cell formation and atherosclerosis Publications span molecular neurobiology, immunology, and biochemistry, with a focus on inflammation, muscle regeneration, and cancer biology. Contreras-Shannon is actively engaged in mentoring and serves on the American Society for Investigative Pathology Leadership Council.

Brigid E. GreggView profile

Associate Professor

• Metabolic Diseases
• Nutritional Sciences
• Developmental Biology
• +3 more

Brigid E. Gregg is an Associate Professor at the University of Michigan's Medical School in the Department of Pediatrics and the School of Public Health's Department of Nutritional Sciences. She also serves as Assistant Chair in the Department of Pediatrics. University: University of Michigan School: Medical School (Pediatrics) and School of Public Health (Nutritional Sciences) Academic Rank: Associate Professor Dr. Gregg's research focuses on perinatal programming of metabolic diseases, including how early-life nutrient stressors and maternal metabolic health influence offspring risk for obesity, diabetes, and metabolic syndrome. Her work combines animal models and human mother-infant cohorts to study molecular mechanisms in pancreatic beta-cell expansion, adipose tissue, and liver function. Recent publications highlight her studies on maternal nutrition (e.g., DHA enrichment, Mediterranean diet), diabetes treatment (GLP-1/GIP agonists), and the impact of gestational BPA exposure on islet development. The Gregg lab investigates lactation-period nutrient stressors and their long-term effects on metabolic health.

Leslie SatinView profile

Professor

• Pancreatic islet biology
• Beta cell physiology
• Stimulus-secretion coupling
• +7 more

Leslie Satin is a Professor of Pharmacology and Internal Medicine at the University of Michigan Medical School. He serves as the Joanne I. Moore Endowed Research Professor and is affiliated with the Brehm Diabetes Research Center, Caswell Diabetes Institute, and MEND program in Internal Medicine. His research focuses on pancreatic islet biology and beta cell physiology. Research interests include: Beta cell stimulus-secretion coupling Calcium signaling in organelles and cytosol Oscillations in biological systems Mathematical modeling of cellular processes Genetically encoded sensors for live cell imaging Recent publications highlight his work on glucose-mediated insulin secretion dynamics, KATP channel regulation, and endoplasmic reticulum homeostasis in beta cells. His scientific awards include prestigious fellowships and endowed professorships. Scientific awards: Joanne I. Moore Endowed Research Professor Investigator at Brehm Diabetes Research Center Investigator at Caswell Diabetes Institute VA Medical Center fellowship SUNY Stony Brook postdoctoral fellowship Leslie Satin is available to mentor students and maintains an active research program focused on diabetes-related cellular mechanisms.

• Bone marrow microenvironment
• Hematopoietic stem cells
• Leukaemic stem cells
• +4 more

Susann Rahmig is a Postdoctoral Researcher at the University of Oxford , affiliated with the Vyas Group: Biology and Treatment of Human Myeloid Cancers . She holds a PhD, MSc, and BSc, with prior postdoctoral experience in the lab of Claudia Waskow in Germany. Her research focuses on characterizing the bone marrow microenvironment for hematopoietic and leukemic stem cells using humanized mouse models , 3D imaging , and imaging mass cytometry . She employs bone organoids (ossicles) to study niche interactions and their impact on stem cell function. Broad research areas: Bone marrow niche, stem cell biology, leukemia treatment Methodological expertise: Humanized mouse models, 3D imaging, mass cytometry Key publication themes: Stem cell engraftment, epigenetic aging, splicing factors in cancer Current lab: Vyas Group, University of Oxford Recent work (2024) explores mutant stem cell advantages in clonal hematopoiesis and their relationship with inflammation and aging. Her publications span Cell Stem Cell , Cancer Cell , and Stem Cell Reports . No scientific awards are mentioned in available texts.

• Diabetes Research
• Endocrinology
• Islet Physiology
• +3 more

Ioannis Spiliotis is a Clinical Researcher at the Oxford Centre for Diabetes, Endocrinology and Metabolism (University of Oxford) and a Consultant in Diabetes, Endocrinology, and General Medicine at Milton Keynes University Hospital NHS Trust. He holds a DPhil from the University of Oxford and is affiliated with the Rorsman Group. Education: BSc (Hons) in Molecular Biology MBBS (medical degree) MRCP (Membership of the Royal College of Physicians) DPhil (PhD) in Islet Physiology His research focuses on glucagon secretion in diabetes, pharmacological interventions (e.g., sulfonylureas, SGLT2 inhibitors), and translating in vitro findings to clinical trials. Key projects include the LEGEND-D trial for Type 1 Diabetes and studies on MODY. Recent publications highlight his work on hyperglucagonemia, insulin secretion, and SGLT2 inhibition in diabetes. He has led clinical trials such as DEPTH and Glucagon in MODY (NCT03246828). He collaborates with the clinical islet transplantation team at Churchill Hospital and integrates molecular biology with endocrinology in his research.

Erika FERRARIView profile

Associate Professor

• Inorganic Medicinal Chemistry
• Metal-Based Drugs
• Metal Trafficking in vitro
• +7 more

Erika Ferrari is an Associate Professor at the Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia. Her research focuses on inorganic medicinal chemistry , particularly in metal-based drug development , metal trafficking studies , and advanced NMR techniques for complex matrices. She leads projects on inorganic drug delivery systems and theranostic agents , with significant work on curcumin derivatives and bioactive glasses. Current projects include development of 68Ga-labeled radiotracers for Alzheimer's and cancer imaging Environmental applications in soil organic matter analysis and microalgae-based biostimulants Research Highlights: Her work bridges coordination chemistry with pharmaceutical applications , focusing on metal chelation therapy , anticancer agents , and green synthesis methods . Recent publications emphasize mesoporous silica carriers and stabilized curcumin analogs . Teaching: She instructs courses in General and Inorganic Chemistry , Industrial Inorganic Chemistry , and Coordination Compound Chemistry , emphasizing stoichiometry , chemical equilibria , and laboratory safety .

• Reproductive Health
• Obstetrics
• Gynecology
• +3 more

Elena Soukhov, MD, is a Lecturer at the University of Maryland School of Medicine, affiliated with the Department of Obstetrics, Gynecology and Reproductive Sciences. Her clinical focus centers on labor and delivery, with specialized research interests in reproductive endocrinology, including endometriosis, PCOS, recurrent pregnancy loss, and IVF optimization. University of Toronto (BS in Human Biology and Psychology, Minor in Jewish Studies, 2014) Medical School for International Health, Ben Gurion University (MD, 2019) University of Maryland Medical Center (OBGYN Residency, 2023) Dr. Soukhov's research integrates reproductive health with clinical excellence, emphasizing patient-centered care and technical innovation. Her publications span reproductive medicine, neuroscience, and endocrinology, reflecting interdisciplinary expertise. Student Teacher Award (2022) Gold Humanism Award (2019) Clinical Excellence Award (2019) Research Award (2017) She actively contributes to teaching and community engagement, speaking Hebrew, Russian, and English fluently.

Theresa MurphyView profile

Professor

• Immunology
• Dendritic Cell Biology
• Lymphocyte Development
• +4 more

Theresa Murphy serves as a Professor in the Department of Pathology & Immunology at Washington University School of Medicine, specializing in immunological mechanisms with particular emphasis on dendritic cell biology and immune response regulation. Her work bridges fundamental immunology with translational applications in tumor immunology and infectious disease. Her academic foundation includes: BS, Summa Cum Laude, Chemistry, University of Arizona, Tucson, AZ (1978) PhD, Johns Hopkins University School of Medicine, Baltimore, MD (1983) Postdoctoral Training under J. Thomas August, Johns Hopkins University School of Medicine (1983-1984) Dr. Murphy's research program investigates dendritic cell development and lymphocyte subset differentiation, focusing on how immune responses are selected against pathogens and the mechanisms of dendritic cell-mediated tumor rejection. Her work integrates cellular immunology with molecular genetics to uncover fundamental principles of immune regulation, with significant implications for cancer immunotherapy and vaccine development. Current projects explore transcriptional control of immune cell differentiation through enhancer elements and superenhancers. Her publication portfolio demonstrates consistent contributions to dendritic cell biology, monocyte development, and transcriptional regulation, revealing critical roles for factors like Irf8 and C/EBPα in immune cell lineage decisions. The work spans immunology, molecular genetics, and cell biology, with recurring themes in enhancer function and cell-type-specific gene expression. Notable recognitions include: Phi Beta Kappa (1978) Summa Cum Laude (1978) American Institute of Chemists Award for Scholastic Achievement (1978) American Institute of Chemists Award for Scholastic Achievement (1977) Dr. Murphy maintains a collaborative research program within the Immunobiology Division, working closely with Dr. Kenneth Murphy. Her laboratory receives support through institutional funding and likely NIH mechanisms common to established immunology researchers, though specific grants aren't detailed in available sources. She contributes to graduate education through the Washington University Graduate Program in Molecular Genetics and Genomics. As a core member of the Immunobiology Division, she participates in interdisciplinary initiatives studying immune cell development and function, contributing expertise in dendritic cell biology to the broader research ecosystem of the Department of Pathology & Immunology.

Keith MillerView profile

Associate Professor

• Cancer Immunotherapy
• Tissue Engineering
• Biochemistry
• +3 more

Dr. Keith Miller serves as an Associate Professor in the Department of Biochemistry and Chemistry at the University of Mount Union, where he teaches General Chemistry II, Introduction to Biochemistry, Medicinal Chemistry, Advanced Biochemistry Laboratory, and an innovative Honors board game design seminar. His pedagogical approach emphasizes sparking scientific curiosity through real-world connections and primary literature analysis to cultivate critical thinking and lifelong learning habits. His research program focuses on cancer immunotherapy and tissue engineering, specifically developing liposome-based drug delivery systems that target immune cells like macrophages and neutrophils. By manipulating liposome properties including size, charge, and surface chemistry, his laboratory optimizes therapeutic delivery for cancer treatment and immune modulation, bridging biochemistry, immunology, and pharmaceutical sciences. Dr. Miller's publication record reveals dual expertise: educational research on flipped classrooms and literature-based curricula, and biomedical studies on nanoparticle therapeutics and immune cell targeting. His educational innovations enhance student engagement across biochemistry education, while his scientific work advances liposome engineering for precise drug delivery in oncology. No scientific awards were documented in the provided materials. As a dedicated mentor, Dr. Miller supervises undergraduate research projects within his laboratory and encourages students to explore departmental opportunities spanning: Alzheimer’s disease mechanisms Cancer therapeutics development Novel antibiotic discovery Stroke treatment pharmaceuticals Metal toxicity investigations Solar cell and battery technology Regular research journal clubs foster critical analysis of scientific literature among students and faculty, with department-wide open-door policies facilitating academic collaboration. The department maintains a vibrant research ecosystem where Dr. Miller's current projects investigate liposome targeting specificity and macrophage response modulation, contributing to next-generation immunotherapies through interdisciplinary student-faculty collaboration.